Press release
Pharmaceuticals Market 2017 Global Competitors are Financed, and the Mergers and Partnerships
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals Q2 2017", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q2 2017. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/426534
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in Q2 2017 with 1,110 deals worth USD91.3 billion, as compared 1,224 worth USD163.8 billion in Q2 2016. On a quarter-on-quarter basis, the number of deals and deal values decreased in Q2 2017, when compared to 1,185 deals worth USD95.9 billion in Q1 2017. The pharmaceutical and healthcare industry reported a decrease in upfront payments in licensing agreements with USD725.3m in Q2 2017, as compared USD1.1 billion in Q2 2016. On a quarter-on-quarter basis, the upfront payments reported a marginal increase in Q2 2017, when compared to USD723.6m in Q1 2017. Deals in oncology therapeutics market registered a decrease with 374 deals in Q2 2017, compared to 434 deals in Q1 2017. North America reported a decrease in the number of deals from 798 in Q1 2017 to 696 in Q2 2017.
Scope
Analysis of the market trends for the pharmaceutical industry in the global arena.
Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
Analysis of partnership and licensing deals based on clinical stage of development of products.
Summary of the pharmaceutical deals globally in the five quarters.
Information on the top deals happened in the pharmaceutical industry.
Geographies covered include North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Browse the complete report @ http://www.orbisresearch.com/reports/index/partnerships-licensing-investments-and-manda-deals-and-trends-in-pharmaceuticals-q2-2017
Reasons to buy
Enhance your decision making capability in a more rapid and time sensitive manner.
Find out the major deal performing segments for investments in your industry.
Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
Identify companies that are aggressively looking to raise capital in the market
Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
Identify growth segments and opportunities in each region within the industry.
Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Get the Discount on this report @ http://www.orbisresearch.com/contacts/discount/426534
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: sales@orbisresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceuticals Market 2017 Global Competitors are Financed, and the Mergers and Partnerships here
News-ID: 727837 • Views: …
More Releases from Orbis Research
Blood Purification Devices Market 2023-2028 | Top Players Baxter International, …
Based on the type segment, the portable equipment segment is expected to hold the largest share in Blood Purification Devices in the year 2028. Professionals that are actively involved in the ongoing purification of blood tend to favour portable equipment. Equipment that is portable enables effective emergency care. Additionally, portable equipment is rather space-efficient and compact, which promotes widespread use throughout the blood-purification process. In a manner similar to how…
Clean Beauty Market to Grow at 40.1% CAGR by 2028 - Key Players are Bare Mineral …
Clean beauty is described as beauty and personal care products that are made with the safest possible ingredients and have the lowest possible environmental impacts. Clean beauty pertains to products that are safe, non-toxic, and clearly labelled ingredients Also, the ingredients used are cruelty-free and are screened for non-GMO feedstock and residual pesticides.
Request a pdf brochure @ https://www.orbisresearch.com/contacts/request-sample/6941781
The Clean Beauty Market is valued at USD 5163.17 Million in 2021 and…
Outdoor Power Equipment Market Worth USD 6.49 Bn by 2027 - Industry Trends and S …
The outdoor power equipment generally includes, brush cutters, edger, chain saws, power rakes, and more. Outdoor power equipment is commonly used by end users, such as lawn & plant care providers and landscape service providers, for commercial purposes.
The global outdoor power equipment market in 2021 was valued at US$32.22 billion. The market value is projected to reach US$46.49 billion by 2027. Outdoor power equipment (OPE) is an equipment with small…
Merchant API Market to reach US$119.11 billion by 2027 - Industry Trends, Growth …
The latest research on "Global Merchant API Market: Analysis By Molecular Type, By Segment, By Type, By Type of Synthesis, By End-User, By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027" have been added to OrbisResearch.com store.
The merchant API market refers to the use of APIs by merchants, or businesses that sell goods and services, to connect their systems and processes with those of other…
More Releases for M&A
industrials m&a,m&a project management,corporate finance mergers and acquisition …
Mergers and acquisitions (M&A) in the industrial sector refer to the process of one company acquiring another company or assets in the manufacturing, construction, and engineering industries. The industrial sector is characterized by a diverse range of businesses, including heavy machinery, aerospace, and defense, chemicals, and engineering services.
https://upworkservice.com/
China M&A advisory
E-mail:nolan@pandacuads.com
The industrial sector is characterized by a high level of consolidation, with companies looking to acquire other companies to gain access…
m&a company,m&a integration,cross border merger,m&a due diligence,m&a strategy,m …
Mergers and acquisitions (M&A) are a common way for companies to grow and diversify their business operations. The process of merging or acquiring another company can be complex and time-consuming, but when executed successfully, it can bring significant benefits to the acquiring company, such as access to new markets, technologies, and customers.
https://upworkservice.com
China M&A advisory
E-mail:nolan@pandacuads.com
When it comes to successful M&A, the key is to ensure that the two companies are a…
private equity m&a,international mergers and acquisitions,technology m&a,m&a pro …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. In the M&A process, there are two main parties involved: the buyer and the seller. One type of buyer that is becoming increasingly prevalent in the M&A landscape is private equity firms.
https://upworkservice.com/
China M&A advisory
E-mail:nolan@pandacuads.com
Private equity firms are investment firms that raise capital from institutional investors and high net…
buy side m&a,global m&a,bank mergers and acquisitions,m&a advisory firms,success …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. In the M&A process, there are two main parties involved: the buyer and the seller. The term "buy side" refers to the party that is acquiring the target company. In contrast, the "sell side" refers to the party that is being acquired.
https://upworkservice.com/
China M&A advisory
E-mail:nolan@pandacuads.com
The buy side M&A process…
due diligence in mergers and acquisitions,recent m&a deals 2023,m&a management,m …
Due diligence is an investigation process that companies undertake prior to a merger or acquisition (M&A) in order to assess the target company's financial and operational condition. The goal of due diligence is to identify any potential risks or opportunities that may impact the value of the acquisition and to ensure that the deal is in the best interest of the acquiring company. Due diligence is a critical step in…
m&a valuation,corporate mergers,m&a business,merger integration,sell side m&a pr …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. One crucial aspect of the M&A process is the valuation of the target company. Valuation is the process of determining the fair value of a company, and it is an essential step in the M&A process because it helps companies to determine the terms of the acquisition, such…
